ePlus (PLUS)
(Delayed Data from NSDQ)
$100.02 USD
+1.83 (1.86%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $100.01 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth C Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$100.02 USD
+1.83 (1.86%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $100.01 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth C Momentum A VGM
Zacks News
5 Low Price-to-Sales Stocks That Promise Lucrative Returns
by Rajani Lohia
The price-to-sales ratio is a convenient tool to gauge the value of stocks incurring losses or in an early development cycle. Stocks like CRUS, PLUS, GIII, JAKK and UFPI hold promise.
5 Low Price-to-Sales Stocks to Keep Your Investments Safe
by Rajani Lohia
The price-to-sales ratio is a convenient tool to gauge the value of stocks incurring losses or in an early development cycle. Stocks like B, PLUS, GIII, PAM and UFPI hold promise.
Fast-paced Momentum Stock ePlus (PLUS) Is Still Trading at a Bargain
by Zacks Equity Research
ePlus (PLUS) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Cognizant (CTSH) Partners With Accuray to Improve Healthcare
by Zacks Equity Research
Cognizant's (CTSH) partnership agreement will enable Accuray to streamline and drive operational changes to improve patient care.
Zacks Investment Ideas feature highlights: ePlus, Rush Enterprises and Sterling Infrastructure
by Zacks Equity Research
ePlus, Rush Enterprises and Sterling Infrastructure have been highlighted in this Investment Ideas article.
3 Intriguing Stocks to Buy for Value and Growth Potential
by Shaun Pruitt
These companies are attractively placed in their industries as leaders that can benefit from economic expansion.
5 Low Price-to-Sales Stocks to Keep Your Portfolio in Profit
by Rajani Lohia
The price-to-sales ratio is a convenient tool to gauge the value of stocks incurring losses or in an early development cycle. Stocks like B, PLUS, PAM, GIII and UFPI hold promise.
Why Fast-paced Mover ePlus (PLUS) Is a Great Choice for Value Investors
by Zacks Equity Research
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, ePlus (PLUS) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
What Makes ePlus (PLUS) a New Strong Buy Stock
by Zacks Equity Research
ePlus (PLUS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks Industry Outlook Highlights MSCI (MSCI), Tyler Technologies, Guidewire Software and ePlus
by Zacks Equity Research
MSCI (MSCI), Tyler Technologies, Guidewire Software and ePlus have been highlighted in this Industry Outlook article.
4 Business-Software Services Stocks to Watch in a Thriving Industry
by Anirudha Bhagat
The Zacks Business-Software Services industry players like MSCI, TYL, GWRE and PLUS are poised to continue benefiting from the increasing demand for multi-cloud-enabled software solutions amid the accelerated digital transformation and a shift to cloud initiatives.
EPlus (PLUS) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
ePlus (PLUS) delivered earnings and revenue surprises of 28.30% and 2.18%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Q2 Holdings (QTWO) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Q2 Holdings (QTWO) delivered earnings and revenue surprises of 180% and 2.20%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Cognizant (CTSH) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Cognizant (CTSH) delivered earnings and revenue surprises of 5.71% and 1.60%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Tyler Technologies (TYL) Surpasses Q1 Earnings Estimates
by Zacks Equity Research
Tyler Technologies (TYL) delivered earnings and revenue surprises of 2.92% and 0.38%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Cognizant (CTSH) & Microsoft Expand Healthcare Partnership
by Zacks Equity Research
Cognizant (CTSH) announces the expansion of its partnership with Microsoft in the healthcare market by integrating its TriZetto with Microsoft Cloud for Healthcare.
Zacks.com featured highlights CNA Financial, Medallion Financial, ArcelorMittal, KB Home and ePlus
by Zacks Equity Research
CNA Financial, Medallion Financial, ArcelorMittal, KB Home and ePlus have been highlighted in this Screen of The Week article.
Zacks.com featured highlights Compania Cervecerias Unidas, PVH, Concrete Pumping, Ranger Energy Services and ePlus
by Zacks Equity Research
Compania Cervecerias Unidas, PVH, Concrete Pumping, Ranger Energy Services and ePlus have been highlighted in this Screen of The Week article.
These 5 Price-to-Sales Stocks Can Refine Your Portfolio
by Rajani Lohia
The price-to-sales ratio is a convenient tool to gauge the value of stocks incurring losses or in an early development cycle. Stocks like CNA, MFIN, MT, KBH and PLUS hold promise.
5 Value Stocks With Alluring EV-to-EBITDA Ratios to Own Now
by Anindya Barman
We have screened value stocks CCU, PVH, BBCP, RNGR and PLUS based on the EV-to-EBITDA ratio, which offers a clearer picture of valuation and earnings potential.
Oracle (ORCL) Partners With Hibbett to Improve User Experience
by Zacks Equity Research
Oracle (ORCL) is going to be drafted by Hibbett to make its in-store experience better and deliver more customized interactions.
Buy These 5 Price-to-Sales Stocks to Get Standout Returns
by Rajani Lohia
The price-to-sales ratio is a convenient tool to gauge the value of stocks incurring losses or in an early development cycle. Stocks like MT, PAGS, CNA, SKM and PLUS hold promise.
Zacks Industry Outlook Highlights MSCI, Tyler Technologies, TD SYNNEX and ePlus
by Zacks Equity Research
MSCI, Tyler Technologies, TD SYNNEX and ePlus are part of the Zacks Industry Outlook article.
4 Stocks to Watch From the Promising Business-Software Services Industry
by Anirudha Bhagat
The Zacks Business-Software Services industry players like MSCI, TYL, SNX and PLUS are poised to benefit from the robust demand trend for multi-cloud-enabled software solutions.
Despite Fast-paced Momentum, ePlus (PLUS) Is Still a Bargain Stock
by Zacks Equity Research
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, ePlus (PLUS) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.